LincRNA-immunity landscape analysis identifies EPIC1 as a regulator of tumor immune evasion and immunotherapy resistance
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LincRNA-immunity landscape analysis identifies EPIC1 as a regulator of tumor immune evasion and immunotherapy resistance
Authors
Keywords
-
Journal
Science Advances
Volume 7, Issue 7, Pages eabb3555
Publisher
American Association for the Advancement of Science (AAAS)
Online
2021-02-11
DOI
10.1126/sciadv.abb3555
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- RNA is essential for PRC2 chromatin occupancy and function in human pluripotent stem cells
- (2020) Yicheng Long et al. NATURE GENETICS
- Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition
- (2019) Daisuke Ennishi et al. Cancer Discovery
- Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression
- (2019) Qingsong Hu et al. NATURE IMMUNOLOGY
- An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer
- (2019) Marian L. Burr et al. CANCER CELL
- Massively parallel single-cell chromatin landscapes of human immune cell development and intratumoral T cell exhaustion
- (2019) Ansuman T. Satpathy et al. NATURE BIOTECHNOLOGY
- The Role of Non-coding RNAs in Oncology
- (2019) Frank J. Slack et al. CELL
- lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer
- (2018) Zehua Wang et al. CANCER CELL
- The Immune Landscape of Cancer
- (2018) Vésteinn Thorsson et al. IMMUNITY
- Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape
- (2018) Max D. Wellenstein et al. IMMUNITY
- Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
- (2018) Flávia Castro et al. Frontiers in Immunology
- Epigenetic mechanisms of tumor resistance to immunotherapy
- (2018) Natalia Arenas-Ramirez et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Systematic identification of non-coding pharmacogenomic landscape in cancer
- (2018) Yue Wang et al. Nature Communications
- Genomic landscape associated with potential response to anti-CTLA-4 treatment in cancers
- (2017) Chan-Young Ock et al. Nature Communications
- Inhibition of EZH2 Promotes Human Embryonic Stem Cell Differentiation into Mesoderm by Reducing H3K27me3
- (2017) Yongxin Yu et al. Stem Cell Reports
- Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
- (2016) Jianjun Gao et al. CELL
- Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
- (2016) Joseph L. Benci et al. CELL
- Immune Cytolytic Activity Stratifies Molecular Subsets of Human Pancreatic Cancer
- (2016) David Balli et al. CLINICAL CANCER RESEARCH
- The bright side of dark matter: lncRNAs in cancer
- (2016) Joseph R. Evans et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting EZH2 in cancer
- (2016) Kimberly H Kim et al. NATURE MEDICINE
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of the EZH2 histone methyltransferase as a therapeutic target in cancer
- (2016) Antoine Italiano PHARMACOLOGY & THERAPEUTICS
- Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
- (2016) I. Tirosh et al. SCIENCE
- Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease
- (2016) J. Liu et al. Cancer Discovery
- Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations
- (2016) Daniel Sanghoon Shin et al. Cancer Discovery
- DDX5 and its associated lncRNA Rmrp modulate TH17 cell effector functions
- (2015) Wendy Huang et al. NATURE
- Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy
- (2015) Dongjun Peng et al. NATURE
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- (2015) Stefani Spranger et al. NATURE
- Correlating chemical sensitivity and basal gene expression reveals mechanism of action
- (2015) Matthew G Rees et al. Nature Chemical Biology
- The landscape of long noncoding RNAs in the human transcriptome
- (2015) Matthew K Iyer et al. NATURE GENETICS
- The long intergenic noncoding RNA landscape of human lymphocytes highlights the regulation of T cell differentiation by linc-MAF-4
- (2015) Valeria Ranzani et al. NATURE IMMUNOLOGY
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- Expression Atlas update—an integrated database of gene and protein expression in humans, animals and plants
- (2015) Robert Petryszak et al. NUCLEIC ACIDS RESEARCH
- Tissue-based map of the human proteome
- (2015) M. Uhlen et al. SCIENCE
- The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors
- (2015) Daniel Zingg et al. Nature Communications
- Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset
- (2015) B. Seashore-Ludlow et al. Cancer Discovery
- New insights into cancer immunoediting and its three component phases—elimination, equilibrium and escape
- (2014) Deepak Mittal et al. CURRENT OPINION IN IMMUNOLOGY
- Lymphocyte Invasion in IC10/Basal-Like Breast Tumors Is Associated with Wild-Type TP53
- (2014) David Quigley et al. MOLECULAR CANCER RESEARCH
- The STAT3-Binding Long Noncoding RNA lnc-DC Controls Human Dendritic Cell Differentiation
- (2014) P. Wang et al. SCIENCE
- EZH2 mutations are frequent and represent an early event in follicular lymphoma
- (2013) C. Bodor et al. BLOOD
- An Interactive Resource to Identify Cancer Genetic and Lineage Dependencies Targeted by Small Molecules
- (2013) Amrita Basu et al. CELL
- The NeST Long ncRNA Controls Microbial Susceptibility and Epigenetic Activation of the Interferon-γ Locus
- (2013) J. Antonio Gomez et al. CELL
- The Cancer Genome Atlas Pan-Cancer analysis project
- (2013) John N Weinstein et al. NATURE GENETICS
- Expression and regulation of intergenic long noncoding RNAs during T cell development and differentiation
- (2013) Gangqing Hu et al. NATURE IMMUNOLOGY
- Transcriptional regulation by Polycomb group proteins
- (2013) Luciano Di Croce et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Current status and new features of the Consensus Coding Sequence database
- (2013) Catherine M. Farrell et al. NUCLEIC ACIDS RESEARCH
- Activation of β-catenin/TCF targets following loss of the tumor suppressor SNF5
- (2013) E L Mora-Blanco et al. ONCOGENE
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- The Polycomb complex PRC2 and its mark in life
- (2011) Raphaël Margueron et al. NATURE
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Epigenetic Antagonism between Polycomb and SWI/SNF Complexes during Oncogenic Transformation
- (2010) Boris G. Wilson et al. CANCER CELL
- Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
- (2010) Ryan D Morin et al. NATURE GENETICS
- Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway
- (2010) Zainab Jagani et al. NATURE MEDICINE
- Molecular Mechanisms of IFN-γ to Up-Regulate MHC Class I Antigen Processing and Presentation
- (2009) Fang Zhou INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
- (2009) David A. Barbie et al. NATURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started